Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Resistant Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00976755
What this trial is testing

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 37
Testing effectiveness (Phase 2)Study completedNCT01083368
What this trial is testing

Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00054574
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT02429804
What this trial is testing

NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma
Stanford University 4
Testing effectiveness (Phase 2)Ended earlyNCT02516670
What this trial is testing

Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaStage IV Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Early research (Phase 1)Looking for participantsNCT07824349
What this trial is testing

JUR-003 in Adult Patients With Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate CancerOligometastatic Prostate Cancer (OMPC)Metastatic Hormone Sensitive Prostate Cancer
Juri Biosciences, Inc. 210
Testing effectiveness (Phase 2)Ended earlyNCT01145508
What this trial is testing

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT01503229
What this trial is testing

Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaRecurrent Prostate Carcinoma+1 more
University of Washington 32
Testing effectiveness (Phase 2)Study completedNCT00939510
What this trial is testing

Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Robert Dreicer MD 32
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Early research (Phase 1)Study completedNCT05544227
What this trial is testing

Phase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Williams Cancer Foundation 15
Testing effectiveness (Phase 2)UnknownNCT03085966
What this trial is testing

Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Shanghai AbelZeta Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00513071
What this trial is testing

AZD0530 in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate Cancer
National Cancer Institute (NCI) 28
Not applicableNot Yet RecruitingNCT07154914
What this trial is testing

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cance
Anhui Medical University 396
Testing effectiveness (Phase 2)Study completedNCT01338792
What this trial is testing

Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-resistant Prostate CancerRecurrent Prostate Cancer
University of Southern California 47
Testing effectiveness (Phase 2)Study completedNCT00448409
What this trial is testing

Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 27
Early research (Phase 1)Looking for participantsNCT05283330
What this trial is testing

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Who this might be right for
Cervical CancerBreast CancerColon Cancer+4 more
Orano Med Theranostics, SAS 48
Testing effectiveness (Phase 2)Study completedNCT01243385
What this trial is testing

Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 44
Not applicableLooking for participantsNCT06334120
What this trial is testing

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Who this might be right for
Non-metastatic Castration-resistant Prostate CancerMetastatic Hormone-sensitive Prostate Cancer
Bayer 600
Testing effectiveness (Phase 2)WithdrawnNCT02966587
What this trial is testing

Durvalumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneHormone-Resistant Prostate CancerMicrosatellite Instability
University of Washington
Next Page